Sunday, May 02, 2021 4:01:41 PM
I view shorts the way I view non problems. A problem is resolved with a solution, but no matter how many times you try to resolve a non problem, it keeps coming back at you. All who've seen it before recognize it's a non problem, but a new audience will question, is it really a problem.
I suspect that when we get TLD AdamF will attempt to re-write history and make it sound like he's believe in NWBO all along. I see AdamF as the King of the non-problem, he creates doubt where their should be none everywhere he goes.
A month from tomorrow I believe the tale will be told, if it hasn't been before, as Dr. Liau's late breaking Abstract for ASCO should be revealed. If I'm wrong about ASCO, I'm sorry, but when I suggest it late last year people thought it too far away, now it's not and I hope a decision wasn't made to pass it up for a Journal. I believe that a Journal could follow shortly after it and be a more complete presentation than can be made in the time allotted at ASCO.
Dr. Liau makes many appearances annually, she certainly has referred to DCVax-L in the past, but it's been since SNO in 2018 that she's done a presentation limited to DCVax-L. I believe that's what ASCO will be for her and others who'll join her in the virtual presentation. Hopefully it will be available on the corporate website shortly thereafter.
Gary
I suspect that when we get TLD AdamF will attempt to re-write history and make it sound like he's believe in NWBO all along. I see AdamF as the King of the non-problem, he creates doubt where their should be none everywhere he goes.
A month from tomorrow I believe the tale will be told, if it hasn't been before, as Dr. Liau's late breaking Abstract for ASCO should be revealed. If I'm wrong about ASCO, I'm sorry, but when I suggest it late last year people thought it too far away, now it's not and I hope a decision wasn't made to pass it up for a Journal. I believe that a Journal could follow shortly after it and be a more complete presentation than can be made in the time allotted at ASCO.
Dr. Liau makes many appearances annually, she certainly has referred to DCVax-L in the past, but it's been since SNO in 2018 that she's done a presentation limited to DCVax-L. I believe that's what ASCO will be for her and others who'll join her in the virtual presentation. Hopefully it will be available on the corporate website shortly thereafter.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
